Clinical Trial: Subject Reported Target-lesion Numeric Rating Scale Evaluation by Subjects With Plaque Psoriasis Treated With Clobex® (Clobetasol Propionate) Spray 0.05%

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Subject Reported Target-lesion Numeric Rating Scale Evaluation by Subjects With Plaque Psoriasis Treated With Clobex® (Clobetasol Propionate) Spray 0.05%

Brief Summary: The aim of this study is to investigate the utility of a technological based rating scale for assessing improvement in plaque psoriasis with Clobex spray treatment.

Detailed Summary:
Sponsor: Galderma Laboratories, L.P.

Current Primary Outcome: Subject Reported Target Lesion Severity Score. [ Time Frame: 2 weeks ]

Subject reported mean scores of the target lesion numeric rating scale (TL-NRS; scale of 0 (no psoriasis) to 10 (very severe psoriasis)) at end of study.


Original Primary Outcome: Relationship Between Digital Photographs of a Target Lesion and Investigator an Subject Reported Severity Scores [ Time Frame: 2 weeks ]

Current Secondary Outcome:

  • Investigator Reported Effectiveness Scores [ Time Frame: 2 weeks ]
  • Subject Reported Effectiveness Scores [ Time Frame: 2 weeks ]


Original Secondary Outcome: Same as current

Information By: Galderma Laboratories, L.P.

Dates:
Date Received: June 26, 2013
Date Started: July 2013
Date Completion:
Last Updated: September 3, 2014
Last Verified: August 2014